Tenpoint Therapeutics GmbH

Tenpoint Therapeutics is a biotechnology company with locations in the UK, Switzerland and the US, and is committed to advancing engineered cell-based therapies and in vivo reprogramming to restore vision for people with degenerative ocular diseases.

We are embracing a new opportunity to fundamentally reshape what’s possible in the lives of people with ocular diseases. We bring together the global experts who are shaping the regenerative ocular medicine revolution and the technologies that are powering it.